Management of Breast Cancer Brain Metastases

Diagnosis of central nervous system (CNS) involvement is now more common in patients with breast cancer as therapy for metastatic disease is improving. Because brain metastases are often managed by physicians from multiple disciplines, multidisciplinary consultation prior to treatment is encouraged for optimal planning. It is now reasonable to treat some patients with brain metastases (i.e., those with asymptomatic brain metastases) with systemic therapy upfront instead of upfront stereotactic radiosurgery (SRS) or whole brain radiation therapy (WBRT).

Target Audience

This educational program is designed to meet the educational needs of physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other health care professionals who manage patients with breast cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Recognize the frequency of brain metastases in patients with breast cancer and presenting signs and symptoms of metastases.
  • Review the efficacy and potential effects on cognitive function and quality of life related to local treatment of brain metastases, such as stereotactic radiosurgery and whole brain radiation therapy.
  • Identify systemic therapy options for patients with brain metastases from breast cancer.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • AstraZeneca
  • Biotheranostics, Inc.
  • Daiichi Sankyo
  • Gilead Sciences
  • Novartis
  • Pfizer
  • Puma Biotechnology

This activity is supported by an independent medical education grant from Bristol Myers Squibb.

This activity is supported by an independent educational grant from Merck & Co., Inc.

Course summary
Available credit: 
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
Course opens: 
03/15/2021
Course expires: 
03/15/2022
Cost:
$0.00

Louis B. Nabors, MD
O'Neal Comprehensive Cancer Center at UAB

 

NCCN Medical Education Disclosure Policy

It is the policy of NCCN that every 12 months, all faculty, moderators, activity planners and all internal planning staff participating in NCCN continuing education activities are expected to disclose any financial relationships with a commercial interest as defined by the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. In addition, all faculty presentations have been reviewed for adherence to the ACCME’s Standards for Commercial Support (the provider develops activities/educational interventions independent of commercial interests [SCS 1, 2 and 6] by experts on the topics).

Per the ACCME Standards for Commercial Support, individuals who do not disclose relevant financial relationships will be disqualified from involvement in the CE activity as a content developer, planner, or presenter. A complete list of individuals’ relationships with external entities is available upon request.

Definitions  

NCCN continuing education considers financial relationships to create a “conflict of interest” when an individual has both a financial relationship with a commercial interest and the opportunity to affect CE content about the products or services of a commercial interest with which he/she and/or a spouse or partner has a financial relationship.

NCCN continuing education considers “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. NCCN does not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. 

Faculty Disclaimers  

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling.

Faculty Disclosures

The faculty listed below discloses the following relevant financial relationships:

Louis B. Nabors, MD 
BTG: Scientific Advisor 
Karyopharm Therapeutics: Scientific Advisor 

NCCN Staff Disclosures

The NCCN Activity Planning staff listed below discloses no relevant financial relationships:

Mike Abrams; Melissa Esplen; Mark A. Geisler; Kristina M. Gregory, RN, MSN, OCN; Kristin Kline Hasson; Rose Joyce; Karen Kanefield; Lisa Perfidio, MS; Shannon Ryan, CMP; Kathy Ann Smith, CHCP; Sarah Weinstein

The NCCN Clinical staff listed below discloses no relevant financial relationships:

Mary Ann Bergman; Susan D. Darlow, PhD

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
NCCN designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
NCCN designates this educational activity for a maximum of 0.5 contact hour.

Pharmacists
NCCN designates this knowledge-based continuing education activity for 0.5 contact hour (0.05 CEUs) of continuing education credit. UAN: JA4008196-0000-21-032-H01-P

Physician Assistants 
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credit. Approval is valid until March 15, 2022. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection
  • An HTML5 capable browser for video or audio playback
  • Adobe Reader or other PDF reader software for certificate viewing/printing